[Fish oils and rheumatoid arthritis. A randomized and double-blind study]. 1994

K L Faarvang, and G L Nielsen, and B S Thomsen, and K L Teglbjaerg, and T M Hansen, and H H Lervang, and E B Schmidt, and J Dyerberg, and E Ernst
Reumatologisk afdeling, Amtssygehuset i Herlev.

The effect of dietary supplementation with n-3 polyunsaturated fatty acids (n-3 PUFA) on disease variables in patients with active rheumatoid arthritis was evaluated in a multicentre, randomized and double blind study. Fifty-one patients with active rheumatoid arthritis were included from three Danish hospital Departments of Rheumatology. The patients were allocated to 12 weeks of treatment with either six n-3 PUFA capsules (3.6 g) or six capsules with a fat composition averaging the Danish diet. Small but significant improvements in morning stiffness, joint tenderness and C-reactive protein were observed. There were no serious side-effects. Dietary supplementation with n-3 PUFA in patients with active rheumatoid arthritis has a modest effect on three out of eight disease variables, without effect on other traditional parameters for monitoring disease activity.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005395 Fish Oils Oils high in unsaturated fats extracted from the bodies of fish or fish parts, especially the LIVER. Those from the liver are usually high in VITAMIN A. The oils are used as DIETARY SUPPLEMENTS. They are also used in soaps and detergents and as protective coatings. Fish Liver Oils,Fish Oil,Liver Oils, Fish,Oil, Fish,Oils, Fish,Oils, Fish Liver
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015525 Fatty Acids, Omega-3 A group of unsaturated fatty acids occurring mainly in fish oils, with three double bonds at particular positions in the hydrocarbon chain. N-3 Fatty Acid,Omega-3 Fatty Acid,Omega-3 Fatty Acids,n-3 Fatty Acids,n-3 Oil,n3 Oil,Omega 3 Fatty Acids,n-3 Oils,n-3 PUFA,n-3 Polyunsaturated Fatty Acid,n3 Fatty Acid,n3 Oils,n3 PUFA,n3 Polyunsaturated Fatty Acid,Acid, N-3 Fatty,Acid, Omega-3 Fatty,Fatty Acid, N-3,Fatty Acid, Omega-3,Fatty Acid, n3,N 3 Fatty Acid,Oil, n-3,Oil, n3,Omega 3 Fatty Acid,PUFA, n-3,PUFA, n3,n 3 Fatty Acids,n 3 Oil,n 3 Oils,n 3 PUFA,n 3 Polyunsaturated Fatty Acid

Related Publications

K L Faarvang, and G L Nielsen, and B S Thomsen, and K L Teglbjaerg, and T M Hansen, and H H Lervang, and E B Schmidt, and J Dyerberg, and E Ernst
June 1994, Ugeskrift for laeger,
K L Faarvang, and G L Nielsen, and B S Thomsen, and K L Teglbjaerg, and T M Hansen, and H H Lervang, and E B Schmidt, and J Dyerberg, and E Ernst
November 1987, Lancet (London, England),
K L Faarvang, and G L Nielsen, and B S Thomsen, and K L Teglbjaerg, and T M Hansen, and H H Lervang, and E B Schmidt, and J Dyerberg, and E Ernst
September 1987, Lancet (London, England),
K L Faarvang, and G L Nielsen, and B S Thomsen, and K L Teglbjaerg, and T M Hansen, and H H Lervang, and E B Schmidt, and J Dyerberg, and E Ernst
June 1988, Annals of internal medicine,
K L Faarvang, and G L Nielsen, and B S Thomsen, and K L Teglbjaerg, and T M Hansen, and H H Lervang, and E B Schmidt, and J Dyerberg, and E Ernst
January 1980, Scandinavian journal of rheumatology. Supplement,
K L Faarvang, and G L Nielsen, and B S Thomsen, and K L Teglbjaerg, and T M Hansen, and H H Lervang, and E B Schmidt, and J Dyerberg, and E Ernst
January 2014, Evidence-based complementary and alternative medicine : eCAM,
K L Faarvang, and G L Nielsen, and B S Thomsen, and K L Teglbjaerg, and T M Hansen, and H H Lervang, and E B Schmidt, and J Dyerberg, and E Ernst
January 1980, The Journal of rheumatology,
K L Faarvang, and G L Nielsen, and B S Thomsen, and K L Teglbjaerg, and T M Hansen, and H H Lervang, and E B Schmidt, and J Dyerberg, and E Ernst
October 2006, Rheumatology international,
K L Faarvang, and G L Nielsen, and B S Thomsen, and K L Teglbjaerg, and T M Hansen, and H H Lervang, and E B Schmidt, and J Dyerberg, and E Ernst
May 2006, Rheumatology (Oxford, England),
K L Faarvang, and G L Nielsen, and B S Thomsen, and K L Teglbjaerg, and T M Hansen, and H H Lervang, and E B Schmidt, and J Dyerberg, and E Ernst
November 1989, Annals of internal medicine,
Copied contents to your clipboard!